nodes	percent_of_prediction	percent_of_DWPC	metapath
Dronabinol—ABCB1—Mitomycin—urinary bladder cancer	0.092	0.131	CbGbCtD
Dronabinol—CYP2A6—Fluorouracil—urinary bladder cancer	0.0678	0.0964	CbGbCtD
Dronabinol—ABCG2—Fluorouracil—urinary bladder cancer	0.0628	0.0893	CbGbCtD
Dronabinol—ABCG2—Carboplatin—urinary bladder cancer	0.0624	0.0887	CbGbCtD
Dronabinol—ABCG2—Cisplatin—urinary bladder cancer	0.0533	0.0758	CbGbCtD
Dronabinol—ABCG2—Etoposide—urinary bladder cancer	0.0524	0.0745	CbGbCtD
Dronabinol—PTGS1—Etoposide—urinary bladder cancer	0.0484	0.0688	CbGbCtD
Dronabinol—CYP3A4—Thiotepa—urinary bladder cancer	0.0418	0.0594	CbGbCtD
Dronabinol—ABCG2—Doxorubicin—urinary bladder cancer	0.0357	0.0508	CbGbCtD
Dronabinol—ABCG2—Methotrexate—urinary bladder cancer	0.0346	0.0492	CbGbCtD
Dronabinol—ABCB1—Gemcitabine—urinary bladder cancer	0.0265	0.0376	CbGbCtD
Dronabinol—CYP2C9—Fluorouracil—urinary bladder cancer	0.0233	0.0332	CbGbCtD
Dronabinol—CYP2C9—Cisplatin—urinary bladder cancer	0.0198	0.0282	CbGbCtD
Dronabinol—ABCB1—Cisplatin—urinary bladder cancer	0.0192	0.0273	CbGbCtD
Dronabinol—ABCB1—Etoposide—urinary bladder cancer	0.0189	0.0269	CbGbCtD
Dronabinol—ABCB1—Doxorubicin—urinary bladder cancer	0.0129	0.0183	CbGbCtD
Dronabinol—ABCB1—Methotrexate—urinary bladder cancer	0.0125	0.0177	CbGbCtD
Dronabinol—CYP3A4—Etoposide—urinary bladder cancer	0.0113	0.0161	CbGbCtD
Dronabinol—CYP3A4—Doxorubicin—urinary bladder cancer	0.00772	0.011	CbGbCtD
Dronabinol—CNR1—prostate gland—urinary bladder cancer	0.00725	0.139	CbGeAlD
Dronabinol—CYP2C19—urine—urinary bladder cancer	0.00505	0.0969	CbGeAlD
Dronabinol—CYP2C9—urine—urinary bladder cancer	0.00392	0.0751	CbGeAlD
Dronabinol—CYP3A4—urine—urinary bladder cancer	0.00299	0.0573	CbGeAlD
Dronabinol—CYP2A6—prostate gland—urinary bladder cancer	0.00282	0.0541	CbGeAlD
Dronabinol—CYP2A6—seminal vesicle—urinary bladder cancer	0.00238	0.0458	CbGeAlD
Dronabinol—CNR1—lymph node—urinary bladder cancer	0.00232	0.0444	CbGeAlD
Dronabinol—ABCG2—prostate gland—urinary bladder cancer	0.00154	0.0295	CbGeAlD
Dronabinol—CYP2A6—vagina—urinary bladder cancer	0.00139	0.0267	CbGeAlD
Dronabinol—ABCG2—seminal vesicle—urinary bladder cancer	0.0013	0.025	CbGeAlD
Dronabinol—PTGS1—prostate gland—urinary bladder cancer	0.00128	0.0246	CbGeAlD
Dronabinol—PTGS1—seminal vesicle—urinary bladder cancer	0.00109	0.0208	CbGeAlD
Dronabinol—CYP1A1—epithelium—urinary bladder cancer	0.00107	0.0206	CbGeAlD
Dronabinol—ABCG2—urethra—urinary bladder cancer	0.00103	0.0198	CbGeAlD
Dronabinol—CYP1A1—renal system—urinary bladder cancer	0.000996	0.0191	CbGeAlD
Dronabinol—CYP1A1—urethra—urinary bladder cancer	0.000978	0.0188	CbGeAlD
Dronabinol—PTGS1—epithelium—urinary bladder cancer	0.000943	0.0181	CbGeAlD
Dronabinol—PTGS1—smooth muscle tissue—urinary bladder cancer	0.000909	0.0174	CbGeAlD
Dronabinol—CYP2C19—vagina—urinary bladder cancer	0.000895	0.0172	CbGeAlD
Dronabinol—PTGS1—renal system—urinary bladder cancer	0.000875	0.0168	CbGeAlD
Dronabinol—CYP1A1—female reproductive system—urinary bladder cancer	0.000797	0.0153	CbGeAlD
Dronabinol—CYP2C9—female reproductive system—urinary bladder cancer	0.000767	0.0147	CbGeAlD
Dronabinol—ABCG2—vagina—urinary bladder cancer	0.00076	0.0146	CbGeAlD
Dronabinol—ABCB1—prostate gland—urinary bladder cancer	0.000759	0.0146	CbGeAlD
Dronabinol—CYP3A4—renal system—urinary bladder cancer	0.000731	0.014	CbGeAlD
Dronabinol—CYP1A1—vagina—urinary bladder cancer	0.000721	0.0138	CbGeAlD
Dronabinol—PTGS1—female reproductive system—urinary bladder cancer	0.0007	0.0134	CbGeAlD
Dronabinol—ABCB1—seminal vesicle—urinary bladder cancer	0.000642	0.0123	CbGeAlD
Dronabinol—PTGS1—vagina—urinary bladder cancer	0.000634	0.0122	CbGeAlD
Dronabinol—Rhinitis—Gemcitabine—urinary bladder cancer	0.000613	0.00422	CcSEcCtD
Dronabinol—Rhinitis—Fluorouracil—urinary bladder cancer	0.000603	0.00415	CcSEcCtD
Dronabinol—Thinking abnormal—Doxorubicin—urinary bladder cancer	0.000589	0.00406	CcSEcCtD
Dronabinol—CYP3A4—female reproductive system—urinary bladder cancer	0.000585	0.0112	CbGeAlD
Dronabinol—ABCB1—epithelium—urinary bladder cancer	0.000558	0.0107	CbGeAlD
Dronabinol—Immune system disorder—Gemcitabine—urinary bladder cancer	0.000552	0.00381	CcSEcCtD
Dronabinol—Cough—Thiotepa—urinary bladder cancer	0.000552	0.0038	CcSEcCtD
Dronabinol—Chills—Gemcitabine—urinary bladder cancer	0.000548	0.00378	CcSEcCtD
Dronabinol—Convulsion—Thiotepa—urinary bladder cancer	0.000548	0.00378	CcSEcCtD
Dronabinol—Myalgia—Thiotepa—urinary bladder cancer	0.000539	0.00371	CcSEcCtD
Dronabinol—Anxiety—Thiotepa—urinary bladder cancer	0.000537	0.0037	CcSEcCtD
Dronabinol—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—urinary bladder cancer	0.000535	0.00369	CcSEcCtD
Dronabinol—Tinnitus—Cisplatin—urinary bladder cancer	0.000531	0.00366	CcSEcCtD
Dronabinol—Flushing—Cisplatin—urinary bladder cancer	0.000529	0.00364	CcSEcCtD
Dronabinol—Confusional state—Thiotepa—urinary bladder cancer	0.000521	0.00359	CcSEcCtD
Dronabinol—ABCB1—renal system—urinary bladder cancer	0.000517	0.00992	CbGeAlD
Dronabinol—Immune system disorder—Cisplatin—urinary bladder cancer	0.000515	0.00355	CcSEcCtD
Dronabinol—ABCB1—urethra—urinary bladder cancer	0.000508	0.00975	CbGeAlD
Dronabinol—Nervous system disorder—Thiotepa—urinary bladder cancer	0.000506	0.00349	CcSEcCtD
Dronabinol—Mental disability—Epirubicin—urinary bladder cancer	0.000506	0.00348	CcSEcCtD
Dronabinol—Tachycardia—Thiotepa—urinary bladder cancer	0.000504	0.00347	CcSEcCtD
Dronabinol—Skin disorder—Thiotepa—urinary bladder cancer	0.000501	0.00346	CcSEcCtD
Dronabinol—Ill-defined disorder—Gemcitabine—urinary bladder cancer	0.000494	0.0034	CcSEcCtD
Dronabinol—Anorexia—Thiotepa—urinary bladder cancer	0.000492	0.00339	CcSEcCtD
Dronabinol—ABCG2—lymph node—urinary bladder cancer	0.000491	0.00943	CbGeAlD
Dronabinol—Flushing—Etoposide—urinary bladder cancer	0.000484	0.00334	CcSEcCtD
Dronabinol—Malaise—Gemcitabine—urinary bladder cancer	0.00048	0.00331	CcSEcCtD
Dronabinol—Immune system disorder—Etoposide—urinary bladder cancer	0.000471	0.00325	CcSEcCtD
Dronabinol—Musculoskeletal discomfort—Thiotepa—urinary bladder cancer	0.00047	0.00324	CcSEcCtD
Dronabinol—Chills—Etoposide—urinary bladder cancer	0.000468	0.00323	CcSEcCtD
Dronabinol—Mental disability—Doxorubicin—urinary bladder cancer	0.000468	0.00322	CcSEcCtD
Dronabinol—CYP1A1—lymph node—urinary bladder cancer	0.000466	0.00895	CbGeAlD
Dronabinol—Cough—Gemcitabine—urinary bladder cancer	0.000464	0.0032	CcSEcCtD
Dronabinol—Ill-defined disorder—Cisplatin—urinary bladder cancer	0.00046	0.00317	CcSEcCtD
Dronabinol—Somnolence—Thiotepa—urinary bladder cancer	0.000459	0.00316	CcSEcCtD
Dronabinol—Convulsion—Fluorouracil—urinary bladder cancer	0.000453	0.00312	CcSEcCtD
Dronabinol—Myalgia—Gemcitabine—urinary bladder cancer	0.000453	0.00312	CcSEcCtD
Dronabinol—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—urinary bladder cancer	0.00045	0.0031	CcSEcCtD
Dronabinol—Decreased appetite—Thiotepa—urinary bladder cancer	0.000449	0.00309	CcSEcCtD
Dronabinol—Discomfort—Gemcitabine—urinary bladder cancer	0.000448	0.00308	CcSEcCtD
Dronabinol—Malaise—Cisplatin—urinary bladder cancer	0.000447	0.00308	CcSEcCtD
Dronabinol—Myalgia—Fluorouracil—urinary bladder cancer	0.000445	0.00307	CcSEcCtD
Dronabinol—Fatigue—Thiotepa—urinary bladder cancer	0.000445	0.00307	CcSEcCtD
Dronabinol—Discomfort—Fluorouracil—urinary bladder cancer	0.00044	0.00303	CcSEcCtD
Dronabinol—Confusional state—Fluorouracil—urinary bladder cancer	0.000431	0.00297	CcSEcCtD
Dronabinol—Convulsion—Cisplatin—urinary bladder cancer	0.00043	0.00296	CcSEcCtD
Dronabinol—Nervous system disorder—Gemcitabine—urinary bladder cancer	0.000426	0.00294	CcSEcCtD
Dronabinol—Feeling abnormal—Thiotepa—urinary bladder cancer	0.000425	0.00293	CcSEcCtD
Dronabinol—Ataxia—Methotrexate—urinary bladder cancer	0.000425	0.00293	CcSEcCtD
Dronabinol—Myalgia—Cisplatin—urinary bladder cancer	0.000422	0.00291	CcSEcCtD
Dronabinol—Gastrointestinal pain—Thiotepa—urinary bladder cancer	0.000422	0.00291	CcSEcCtD
Dronabinol—Skin disorder—Gemcitabine—urinary bladder cancer	0.000422	0.00291	CcSEcCtD
Dronabinol—Ill-defined disorder—Etoposide—urinary bladder cancer	0.000422	0.00291	CcSEcCtD
Dronabinol—Anxiety—Cisplatin—urinary bladder cancer	0.000421	0.0029	CcSEcCtD
Dronabinol—Hyperhidrosis—Gemcitabine—urinary bladder cancer	0.00042	0.00289	CcSEcCtD
Dronabinol—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—urinary bladder cancer	0.000419	0.00289	CcSEcCtD
Dronabinol—Nervous system disorder—Fluorouracil—urinary bladder cancer	0.000419	0.00289	CcSEcCtD
Dronabinol—Discomfort—Cisplatin—urinary bladder cancer	0.000417	0.00288	CcSEcCtD
Dronabinol—Tachycardia—Fluorouracil—urinary bladder cancer	0.000417	0.00287	CcSEcCtD
Dronabinol—ABCB1—female reproductive system—urinary bladder cancer	0.000414	0.00795	CbGeAlD
Dronabinol—Anorexia—Gemcitabine—urinary bladder cancer	0.000414	0.00285	CcSEcCtD
Dronabinol—PTGS1—lymph node—urinary bladder cancer	0.00041	0.00786	CbGeAlD
Dronabinol—Malaise—Etoposide—urinary bladder cancer	0.00041	0.00282	CcSEcCtD
Dronabinol—Abdominal pain—Thiotepa—urinary bladder cancer	0.000408	0.00281	CcSEcCtD
Dronabinol—Anorexia—Fluorouracil—urinary bladder cancer	0.000407	0.00281	CcSEcCtD
Dronabinol—Hypotension—Gemcitabine—urinary bladder cancer	0.000406	0.0028	CcSEcCtD
Dronabinol—Hypotension—Fluorouracil—urinary bladder cancer	0.000399	0.00275	CcSEcCtD
Dronabinol—Ataxia—Epirubicin—urinary bladder cancer	0.000398	0.00274	CcSEcCtD
Dronabinol—Nervous system disorder—Cisplatin—urinary bladder cancer	0.000397	0.00274	CcSEcCtD
Dronabinol—Cough—Etoposide—urinary bladder cancer	0.000397	0.00273	CcSEcCtD
Dronabinol—Musculoskeletal discomfort—Gemcitabine—urinary bladder cancer	0.000396	0.00273	CcSEcCtD
Dronabinol—Tachycardia—Cisplatin—urinary bladder cancer	0.000395	0.00272	CcSEcCtD
Dronabinol—Convulsion—Etoposide—urinary bladder cancer	0.000394	0.00271	CcSEcCtD
Dronabinol—Skin disorder—Cisplatin—urinary bladder cancer	0.000393	0.00271	CcSEcCtD
Dronabinol—Hyperhidrosis—Cisplatin—urinary bladder cancer	0.000391	0.0027	CcSEcCtD
Dronabinol—Musculoskeletal discomfort—Fluorouracil—urinary bladder cancer	0.000389	0.00268	CcSEcCtD
Dronabinol—Somnolence—Gemcitabine—urinary bladder cancer	0.000386	0.00266	CcSEcCtD
Dronabinol—Anorexia—Cisplatin—urinary bladder cancer	0.000386	0.00266	CcSEcCtD
Dronabinol—Unspecified disorder of skin and subcutaneous tissue—Etoposide—urinary bladder cancer	0.000384	0.00265	CcSEcCtD
Dronabinol—Discomfort—Etoposide—urinary bladder cancer	0.000382	0.00263	CcSEcCtD
Dronabinol—Hypersensitivity—Thiotepa—urinary bladder cancer	0.00038	0.00262	CcSEcCtD
Dronabinol—Somnolence—Fluorouracil—urinary bladder cancer	0.00038	0.00262	CcSEcCtD
Dronabinol—Hypotension—Cisplatin—urinary bladder cancer	0.000378	0.00261	CcSEcCtD
Dronabinol—Decreased appetite—Gemcitabine—urinary bladder cancer	0.000378	0.0026	CcSEcCtD
Dronabinol—ABCB1—vagina—urinary bladder cancer	0.000375	0.00719	CbGeAlD
Dronabinol—Fatigue—Gemcitabine—urinary bladder cancer	0.000374	0.00258	CcSEcCtD
Dronabinol—Confusional state—Etoposide—urinary bladder cancer	0.000374	0.00258	CcSEcCtD
Dronabinol—Decreased appetite—Fluorouracil—urinary bladder cancer	0.000371	0.00256	CcSEcCtD
Dronabinol—Asthenia—Thiotepa—urinary bladder cancer	0.00037	0.00255	CcSEcCtD
Dronabinol—Musculoskeletal discomfort—Cisplatin—urinary bladder cancer	0.000369	0.00254	CcSEcCtD
Dronabinol—Ataxia—Doxorubicin—urinary bladder cancer	0.000368	0.00254	CcSEcCtD
Dronabinol—Pruritus—Thiotepa—urinary bladder cancer	0.000365	0.00252	CcSEcCtD
Dronabinol—Tachycardia—Etoposide—urinary bladder cancer	0.000362	0.00249	CcSEcCtD
Dronabinol—Skin disorder—Etoposide—urinary bladder cancer	0.00036	0.00248	CcSEcCtD
Dronabinol—Hyperhidrosis—Etoposide—urinary bladder cancer	0.000359	0.00247	CcSEcCtD
Dronabinol—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.000358	0.00247	CcSEcCtD
Dronabinol—Anorexia—Etoposide—urinary bladder cancer	0.000354	0.00244	CcSEcCtD
Dronabinol—Diarrhoea—Thiotepa—urinary bladder cancer	0.000353	0.00243	CcSEcCtD
Dronabinol—Decreased appetite—Cisplatin—urinary bladder cancer	0.000352	0.00243	CcSEcCtD
Dronabinol—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.000352	0.00243	CcSEcCtD
Dronabinol—Drowsiness—Methotrexate—urinary bladder cancer	0.000348	0.0024	CcSEcCtD
Dronabinol—Depression—Methotrexate—urinary bladder cancer	0.000347	0.00239	CcSEcCtD
Dronabinol—Hypotension—Etoposide—urinary bladder cancer	0.000347	0.00239	CcSEcCtD
Dronabinol—Dizziness—Thiotepa—urinary bladder cancer	0.000341	0.00235	CcSEcCtD
Dronabinol—Conjunctivitis—Methotrexate—urinary bladder cancer	0.000339	0.00233	CcSEcCtD
Dronabinol—Sweating—Methotrexate—urinary bladder cancer	0.000334	0.0023	CcSEcCtD
Dronabinol—Feeling abnormal—Cisplatin—urinary bladder cancer	0.000334	0.0023	CcSEcCtD
Dronabinol—Somnolence—Etoposide—urinary bladder cancer	0.00033	0.00227	CcSEcCtD
Dronabinol—Drowsiness—Epirubicin—urinary bladder cancer	0.000326	0.00225	CcSEcCtD
Dronabinol—Rash—Thiotepa—urinary bladder cancer	0.000326	0.00224	CcSEcCtD
Dronabinol—Dermatitis—Thiotepa—urinary bladder cancer	0.000325	0.00224	CcSEcCtD
Dronabinol—Headache—Thiotepa—urinary bladder cancer	0.000323	0.00223	CcSEcCtD
Dronabinol—Decreased appetite—Etoposide—urinary bladder cancer	0.000322	0.00222	CcSEcCtD
Dronabinol—Fatigue—Etoposide—urinary bladder cancer	0.00032	0.0022	CcSEcCtD
Dronabinol—Conjunctivitis—Epirubicin—urinary bladder cancer	0.000317	0.00218	CcSEcCtD
Dronabinol—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000315	0.00217	CcSEcCtD
Dronabinol—Sweating—Epirubicin—urinary bladder cancer	0.000312	0.00215	CcSEcCtD
Dronabinol—Asthenia—Gemcitabine—urinary bladder cancer	0.000312	0.00215	CcSEcCtD
Dronabinol—Pruritus—Gemcitabine—urinary bladder cancer	0.000307	0.00212	CcSEcCtD
Dronabinol—Sinusitis—Epirubicin—urinary bladder cancer	0.000306	0.00211	CcSEcCtD
Dronabinol—Feeling abnormal—Etoposide—urinary bladder cancer	0.000306	0.00211	CcSEcCtD
Dronabinol—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000303	0.00209	CcSEcCtD
Dronabinol—Pruritus—Fluorouracil—urinary bladder cancer	0.000302	0.00208	CcSEcCtD
Dronabinol—Drowsiness—Doxorubicin—urinary bladder cancer	0.000302	0.00208	CcSEcCtD
Dronabinol—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000298	0.00206	CcSEcCtD
Dronabinol—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000297	0.00205	CcSEcCtD
Dronabinol—Rhinitis—Epirubicin—urinary bladder cancer	0.000293	0.00202	CcSEcCtD
Dronabinol—Abdominal pain—Etoposide—urinary bladder cancer	0.000293	0.00202	CcSEcCtD
Dronabinol—Conjunctivitis—Doxorubicin—urinary bladder cancer	0.000293	0.00202	CcSEcCtD
Dronabinol—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000292	0.00201	CcSEcCtD
Dronabinol—Tinnitus—Methotrexate—urinary bladder cancer	0.000292	0.00201	CcSEcCtD
Dronabinol—Asthenia—Cisplatin—urinary bladder cancer	0.00029	0.002	CcSEcCtD
Dronabinol—Sweating—Doxorubicin—urinary bladder cancer	0.000289	0.00199	CcSEcCtD
Dronabinol—Sinusitis—Doxorubicin—urinary bladder cancer	0.000283	0.00195	CcSEcCtD
Dronabinol—Immune system disorder—Methotrexate—urinary bladder cancer	0.000282	0.00195	CcSEcCtD
Dronabinol—Dizziness—Fluorouracil—urinary bladder cancer	0.000282	0.00195	CcSEcCtD
Dronabinol—Chills—Methotrexate—urinary bladder cancer	0.000281	0.00193	CcSEcCtD
Dronabinol—Diarrhoea—Cisplatin—urinary bladder cancer	0.000277	0.00191	CcSEcCtD
Dronabinol—Rash—Gemcitabine—urinary bladder cancer	0.000274	0.00189	CcSEcCtD
Dronabinol—Dermatitis—Gemcitabine—urinary bladder cancer	0.000274	0.00189	CcSEcCtD
Dronabinol—Hypersensitivity—Etoposide—urinary bladder cancer	0.000273	0.00188	CcSEcCtD
Dronabinol—Tinnitus—Epirubicin—urinary bladder cancer	0.000273	0.00188	CcSEcCtD
Dronabinol—Headache—Gemcitabine—urinary bladder cancer	0.000272	0.00188	CcSEcCtD
Dronabinol—Flushing—Epirubicin—urinary bladder cancer	0.000272	0.00187	CcSEcCtD
Dronabinol—Rhinitis—Doxorubicin—urinary bladder cancer	0.000271	0.00187	CcSEcCtD
Dronabinol—Rash—Fluorouracil—urinary bladder cancer	0.000269	0.00186	CcSEcCtD
Dronabinol—Dermatitis—Fluorouracil—urinary bladder cancer	0.000269	0.00185	CcSEcCtD
Dronabinol—Headache—Fluorouracil—urinary bladder cancer	0.000268	0.00184	CcSEcCtD
Dronabinol—Asthenia—Etoposide—urinary bladder cancer	0.000266	0.00183	CcSEcCtD
Dronabinol—Immune system disorder—Epirubicin—urinary bladder cancer	0.000264	0.00182	CcSEcCtD
Dronabinol—Chills—Epirubicin—urinary bladder cancer	0.000263	0.00181	CcSEcCtD
Dronabinol—Pruritus—Etoposide—urinary bladder cancer	0.000262	0.00181	CcSEcCtD
Dronabinol—Rash—Cisplatin—urinary bladder cancer	0.000255	0.00176	CcSEcCtD
Dronabinol—Dermatitis—Cisplatin—urinary bladder cancer	0.000255	0.00176	CcSEcCtD
Dronabinol—Diarrhoea—Etoposide—urinary bladder cancer	0.000254	0.00175	CcSEcCtD
Dronabinol—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000253	0.00174	CcSEcCtD
Dronabinol—Tinnitus—Doxorubicin—urinary bladder cancer	0.000252	0.00174	CcSEcCtD
Dronabinol—Flushing—Doxorubicin—urinary bladder cancer	0.000251	0.00173	CcSEcCtD
Dronabinol—Tension—Epirubicin—urinary bladder cancer	0.00025	0.00172	CcSEcCtD
Dronabinol—Nervousness—Epirubicin—urinary bladder cancer	0.000247	0.00171	CcSEcCtD
Dronabinol—Malaise—Methotrexate—urinary bladder cancer	0.000245	0.00169	CcSEcCtD
Dronabinol—Dizziness—Etoposide—urinary bladder cancer	0.000245	0.00169	CcSEcCtD
Dronabinol—Immune system disorder—Doxorubicin—urinary bladder cancer	0.000245	0.00169	CcSEcCtD
Dronabinol—Chills—Doxorubicin—urinary bladder cancer	0.000243	0.00167	CcSEcCtD
Dronabinol—ABCB1—lymph node—urinary bladder cancer	0.000242	0.00465	CbGeAlD
Dronabinol—Cough—Methotrexate—urinary bladder cancer	0.000238	0.00164	CcSEcCtD
Dronabinol—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000236	0.00163	CcSEcCtD
Dronabinol—Convulsion—Methotrexate—urinary bladder cancer	0.000236	0.00163	CcSEcCtD
Dronabinol—Rash—Etoposide—urinary bladder cancer	0.000234	0.00161	CcSEcCtD
Dronabinol—Dermatitis—Etoposide—urinary bladder cancer	0.000234	0.00161	CcSEcCtD
Dronabinol—Headache—Etoposide—urinary bladder cancer	0.000232	0.0016	CcSEcCtD
Dronabinol—Myalgia—Methotrexate—urinary bladder cancer	0.000232	0.0016	CcSEcCtD
Dronabinol—Tension—Doxorubicin—urinary bladder cancer	0.000231	0.00159	CcSEcCtD
Dronabinol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.00023	0.00159	CcSEcCtD
Dronabinol—Malaise—Epirubicin—urinary bladder cancer	0.00023	0.00158	CcSEcCtD
Dronabinol—Discomfort—Methotrexate—urinary bladder cancer	0.000229	0.00158	CcSEcCtD
Dronabinol—Nervousness—Doxorubicin—urinary bladder cancer	0.000229	0.00158	CcSEcCtD
Dronabinol—Palpitations—Epirubicin—urinary bladder cancer	0.000225	0.00155	CcSEcCtD
Dronabinol—Confusional state—Methotrexate—urinary bladder cancer	0.000224	0.00154	CcSEcCtD
Dronabinol—Cough—Epirubicin—urinary bladder cancer	0.000222	0.00153	CcSEcCtD
Dronabinol—Convulsion—Epirubicin—urinary bladder cancer	0.000221	0.00152	CcSEcCtD
Dronabinol—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.000219	0.00151	CcSEcCtD
Dronabinol—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000218	0.0015	CcSEcCtD
Dronabinol—Myalgia—Epirubicin—urinary bladder cancer	0.000217	0.00149	CcSEcCtD
Dronabinol—Anxiety—Epirubicin—urinary bladder cancer	0.000216	0.00149	CcSEcCtD
Dronabinol—Skin disorder—Methotrexate—urinary bladder cancer	0.000216	0.00149	CcSEcCtD
Dronabinol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000215	0.00148	CcSEcCtD
Dronabinol—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000215	0.00148	CcSEcCtD
Dronabinol—Discomfort—Epirubicin—urinary bladder cancer	0.000214	0.00148	CcSEcCtD
Dronabinol—Malaise—Doxorubicin—urinary bladder cancer	0.000213	0.00146	CcSEcCtD
Dronabinol—Dry mouth—Epirubicin—urinary bladder cancer	0.000212	0.00146	CcSEcCtD
Dronabinol—Anorexia—Methotrexate—urinary bladder cancer	0.000212	0.00146	CcSEcCtD
Dronabinol—Confusional state—Epirubicin—urinary bladder cancer	0.00021	0.00144	CcSEcCtD
Dronabinol—Palpitations—Doxorubicin—urinary bladder cancer	0.000208	0.00144	CcSEcCtD
Dronabinol—Hypotension—Methotrexate—urinary bladder cancer	0.000208	0.00143	CcSEcCtD
Dronabinol—Cough—Doxorubicin—urinary bladder cancer	0.000206	0.00142	CcSEcCtD
Dronabinol—Convulsion—Doxorubicin—urinary bladder cancer	0.000204	0.00141	CcSEcCtD
Dronabinol—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000204	0.00141	CcSEcCtD
Dronabinol—Tachycardia—Epirubicin—urinary bladder cancer	0.000203	0.0014	CcSEcCtD
Dronabinol—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000202	0.00139	CcSEcCtD
Dronabinol—Skin disorder—Epirubicin—urinary bladder cancer	0.000202	0.00139	CcSEcCtD
Dronabinol—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000201	0.00139	CcSEcCtD
Dronabinol—Myalgia—Doxorubicin—urinary bladder cancer	0.000201	0.00138	CcSEcCtD
Dronabinol—Anxiety—Doxorubicin—urinary bladder cancer	0.0002	0.00138	CcSEcCtD
Dronabinol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000199	0.00137	CcSEcCtD
Dronabinol—Discomfort—Doxorubicin—urinary bladder cancer	0.000198	0.00137	CcSEcCtD
Dronabinol—Anorexia—Epirubicin—urinary bladder cancer	0.000198	0.00137	CcSEcCtD
Dronabinol—Somnolence—Methotrexate—urinary bladder cancer	0.000197	0.00136	CcSEcCtD
Dronabinol—Dry mouth—Doxorubicin—urinary bladder cancer	0.000196	0.00135	CcSEcCtD
Dronabinol—Hypotension—Epirubicin—urinary bladder cancer	0.000194	0.00134	CcSEcCtD
Dronabinol—Confusional state—Doxorubicin—urinary bladder cancer	0.000194	0.00134	CcSEcCtD
Dronabinol—Decreased appetite—Methotrexate—urinary bladder cancer	0.000193	0.00133	CcSEcCtD
Dronabinol—Fatigue—Methotrexate—urinary bladder cancer	0.000192	0.00132	CcSEcCtD
Dronabinol—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000189	0.00131	CcSEcCtD
Dronabinol—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000189	0.0013	CcSEcCtD
Dronabinol—Tachycardia—Doxorubicin—urinary bladder cancer	0.000188	0.00129	CcSEcCtD
Dronabinol—Skin disorder—Doxorubicin—urinary bladder cancer	0.000187	0.00129	CcSEcCtD
Dronabinol—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000186	0.00128	CcSEcCtD
Dronabinol—Somnolence—Epirubicin—urinary bladder cancer	0.000185	0.00127	CcSEcCtD
Dronabinol—Anorexia—Doxorubicin—urinary bladder cancer	0.000183	0.00126	CcSEcCtD
Dronabinol—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000183	0.00126	CcSEcCtD
Dronabinol—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000182	0.00125	CcSEcCtD
Dronabinol—Decreased appetite—Epirubicin—urinary bladder cancer	0.000181	0.00125	CcSEcCtD
Dronabinol—Hypotension—Doxorubicin—urinary bladder cancer	0.00018	0.00124	CcSEcCtD
Dronabinol—Fatigue—Epirubicin—urinary bladder cancer	0.000179	0.00124	CcSEcCtD
Dronabinol—Abdominal pain—Methotrexate—urinary bladder cancer	0.000176	0.00121	CcSEcCtD
Dronabinol—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000175	0.00121	CcSEcCtD
Dronabinol—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000171	0.00118	CcSEcCtD
Dronabinol—Somnolence—Doxorubicin—urinary bladder cancer	0.000171	0.00118	CcSEcCtD
Dronabinol—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.00017	0.00117	CcSEcCtD
Dronabinol—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000167	0.00115	CcSEcCtD
Dronabinol—Fatigue—Doxorubicin—urinary bladder cancer	0.000166	0.00114	CcSEcCtD
Dronabinol—Abdominal pain—Epirubicin—urinary bladder cancer	0.000164	0.00113	CcSEcCtD
Dronabinol—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000164	0.00113	CcSEcCtD
Dronabinol—Asthenia—Methotrexate—urinary bladder cancer	0.000159	0.0011	CcSEcCtD
Dronabinol—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000159	0.00109	CcSEcCtD
Dronabinol—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000157	0.00108	CcSEcCtD
Dronabinol—Pruritus—Methotrexate—urinary bladder cancer	0.000157	0.00108	CcSEcCtD
Dronabinol—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000153	0.00106	CcSEcCtD
Dronabinol—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000152	0.00105	CcSEcCtD
Dronabinol—Diarrhoea—Methotrexate—urinary bladder cancer	0.000152	0.00105	CcSEcCtD
Dronabinol—Asthenia—Epirubicin—urinary bladder cancer	0.000149	0.00103	CcSEcCtD
Dronabinol—Pruritus—Epirubicin—urinary bladder cancer	0.000147	0.00101	CcSEcCtD
Dronabinol—Dizziness—Methotrexate—urinary bladder cancer	0.000147	0.00101	CcSEcCtD
Dronabinol—Diarrhoea—Epirubicin—urinary bladder cancer	0.000142	0.00098	CcSEcCtD
Dronabinol—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000142	0.000977	CcSEcCtD
Dronabinol—Rash—Methotrexate—urinary bladder cancer	0.00014	0.000965	CcSEcCtD
Dronabinol—Dermatitis—Methotrexate—urinary bladder cancer	0.00014	0.000964	CcSEcCtD
Dronabinol—Headache—Methotrexate—urinary bladder cancer	0.000139	0.000959	CcSEcCtD
Dronabinol—Asthenia—Doxorubicin—urinary bladder cancer	0.000138	0.000951	CcSEcCtD
Dronabinol—Dizziness—Epirubicin—urinary bladder cancer	0.000137	0.000947	CcSEcCtD
Dronabinol—Pruritus—Doxorubicin—urinary bladder cancer	0.000136	0.000938	CcSEcCtD
Dronabinol—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000132	0.000907	CcSEcCtD
Dronabinol—Rash—Epirubicin—urinary bladder cancer	0.000131	0.000903	CcSEcCtD
Dronabinol—Dermatitis—Epirubicin—urinary bladder cancer	0.000131	0.000903	CcSEcCtD
Dronabinol—Headache—Epirubicin—urinary bladder cancer	0.00013	0.000898	CcSEcCtD
Dronabinol—Dizziness—Doxorubicin—urinary bladder cancer	0.000127	0.000877	CcSEcCtD
Dronabinol—Rash—Doxorubicin—urinary bladder cancer	0.000121	0.000836	CcSEcCtD
Dronabinol—Dermatitis—Doxorubicin—urinary bladder cancer	0.000121	0.000835	CcSEcCtD
Dronabinol—Headache—Doxorubicin—urinary bladder cancer	0.00012	0.00083	CcSEcCtD
Dronabinol—PTGS1—Metabolism—NAT2—urinary bladder cancer	4.4e-05	0.000443	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism—SLC19A1—urinary bladder cancer	4.4e-05	0.000443	CbGpPWpGaD
Dronabinol—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	4.35e-05	0.000438	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—ERBB2—urinary bladder cancer	4.35e-05	0.000437	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism—PRSS3—urinary bladder cancer	4.29e-05	0.000432	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism—UGT2B7—urinary bladder cancer	4.24e-05	0.000427	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism—GSTO2—urinary bladder cancer	4.22e-05	0.000425	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism—NAT1—urinary bladder cancer	4.22e-05	0.000425	CbGpPWpGaD
Dronabinol—CYP2A6—Metabolism—NAT2—urinary bladder cancer	4.16e-05	0.000419	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	4.15e-05	0.000418	CbGpPWpGaD
Dronabinol—ABCB1—Metabolism—UGT2B7—urinary bladder cancer	4.14e-05	0.000416	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—CXCL8—urinary bladder cancer	4.12e-05	0.000415	CbGpPWpGaD
Dronabinol—CNR2—Signaling by GPCR—HRAS—urinary bladder cancer	4.09e-05	0.000412	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—CREBBP—urinary bladder cancer	4.07e-05	0.00041	CbGpPWpGaD
Dronabinol—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—urinary bladder cancer	4.05e-05	0.000408	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—IGF1—urinary bladder cancer	4.02e-05	0.000405	CbGpPWpGaD
Dronabinol—CNR1—Signaling by GPCR—EGFR—urinary bladder cancer	4e-05	0.000403	CbGpPWpGaD
Dronabinol—ABCG2—Metabolism—RRM2—urinary bladder cancer	3.96e-05	0.000398	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—IL2—urinary bladder cancer	3.94e-05	0.000396	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism—UGT2B7—urinary bladder cancer	3.86e-05	0.000389	CbGpPWpGaD
Dronabinol—ABCB1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	3.84e-05	0.000387	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—CCND1—urinary bladder cancer	3.84e-05	0.000387	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism—CYP4B1—urinary bladder cancer	3.82e-05	0.000384	CbGpPWpGaD
Dronabinol—PTGS1—Metabolism—RRM2—urinary bladder cancer	3.8e-05	0.000383	CbGpPWpGaD
Dronabinol—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	3.79e-05	0.000382	CbGpPWpGaD
Dronabinol—CNR1—Signaling by GPCR—KRAS—urinary bladder cancer	3.78e-05	0.000381	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—MMP9—urinary bladder cancer	3.73e-05	0.000375	CbGpPWpGaD
Dronabinol—ABCB1—Metabolism—CYP4B1—urinary bladder cancer	3.72e-05	0.000375	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—CDKN1A—urinary bladder cancer	3.71e-05	0.000374	CbGpPWpGaD
Dronabinol—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—urinary bladder cancer	3.71e-05	0.000373	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—PTEN—urinary bladder cancer	3.71e-05	0.000373	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—RHOA—urinary bladder cancer	3.68e-05	0.000371	CbGpPWpGaD
Dronabinol—ABCG2—Metabolism—ENO2—urinary bladder cancer	3.66e-05	0.000369	CbGpPWpGaD
Dronabinol—ABCG2—Metabolism—HPGDS—urinary bladder cancer	3.66e-05	0.000369	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism—SLC19A1—urinary bladder cancer	3.6e-05	0.000363	CbGpPWpGaD
Dronabinol—CYP2A6—Metabolism—RRM2—urinary bladder cancer	3.59e-05	0.000362	CbGpPWpGaD
Dronabinol—ABCG2—Metabolism—GSTT1—urinary bladder cancer	3.55e-05	0.000358	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—EP300—urinary bladder cancer	3.53e-05	0.000356	CbGpPWpGaD
Dronabinol—PTGS1—Metabolism—HPGDS—urinary bladder cancer	3.52e-05	0.000354	CbGpPWpGaD
Dronabinol—PTGS1—Metabolism—ENO2—urinary bladder cancer	3.52e-05	0.000354	CbGpPWpGaD
Dronabinol—ABCB1—Metabolism—SLC19A1—urinary bladder cancer	3.52e-05	0.000354	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism—PRSS3—urinary bladder cancer	3.51e-05	0.000353	CbGpPWpGaD
Dronabinol—PTGS1—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	3.5e-05	0.000352	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism—CYP4B1—urinary bladder cancer	3.48e-05	0.00035	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	3.44e-05	0.000346	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—SRC—urinary bladder cancer	3.44e-05	0.000346	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism—TYMP—urinary bladder cancer	3.43e-05	0.000345	CbGpPWpGaD
Dronabinol—ABCB1—Metabolism—PRSS3—urinary bladder cancer	3.43e-05	0.000345	CbGpPWpGaD
Dronabinol—PTGS1—Metabolism—GSTT1—urinary bladder cancer	3.41e-05	0.000344	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—ERBB2—urinary bladder cancer	3.41e-05	0.000343	CbGpPWpGaD
Dronabinol—PTGS1—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	3.36e-05	0.000338	CbGpPWpGaD
Dronabinol—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	3.35e-05	0.000337	CbGpPWpGaD
Dronabinol—CYP2A6—Metabolism—HPGDS—urinary bladder cancer	3.33e-05	0.000335	CbGpPWpGaD
Dronabinol—CYP2A6—Metabolism—ENO2—urinary bladder cancer	3.33e-05	0.000335	CbGpPWpGaD
Dronabinol—ABCG2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	3.33e-05	0.000335	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	3.29e-05	0.000332	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism—SLC19A1—urinary bladder cancer	3.29e-05	0.000331	CbGpPWpGaD
Dronabinol—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	3.24e-05	0.000326	CbGpPWpGaD
Dronabinol—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	3.24e-05	0.000326	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—CXCL8—urinary bladder cancer	3.23e-05	0.000326	CbGpPWpGaD
Dronabinol—CYP2A6—Metabolism—GSTT1—urinary bladder cancer	3.23e-05	0.000325	CbGpPWpGaD
Dronabinol—CNR1—Signaling by GPCR—HRAS—urinary bladder cancer	3.21e-05	0.000323	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism—PRSS3—urinary bladder cancer	3.2e-05	0.000322	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism—NAT2—urinary bladder cancer	3.1e-05	0.000312	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—IL2—urinary bladder cancer	3.09e-05	0.000311	CbGpPWpGaD
Dronabinol—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	3.09e-05	0.000311	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—MYC—urinary bladder cancer	3.08e-05	0.00031	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—CCND1—urinary bladder cancer	3.01e-05	0.000303	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—EGFR—urinary bladder cancer	3.01e-05	0.000303	CbGpPWpGaD
Dronabinol—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	3e-05	0.000302	CbGpPWpGaD
Dronabinol—ABCG2—Metabolism—NQO1—urinary bladder cancer	2.95e-05	0.000297	CbGpPWpGaD
Dronabinol—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	2.94e-05	0.000296	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—MMP9—urinary bladder cancer	2.93e-05	0.000294	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—CDKN1A—urinary bladder cancer	2.91e-05	0.000293	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—PTEN—urinary bladder cancer	2.91e-05	0.000293	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—KRAS—urinary bladder cancer	2.85e-05	0.000286	CbGpPWpGaD
Dronabinol—PTGS1—Metabolism—NQO1—urinary bladder cancer	2.84e-05	0.000286	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	2.82e-05	0.000283	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism—TYMP—urinary bladder cancer	2.81e-05	0.000283	CbGpPWpGaD
Dronabinol—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	2.79e-05	0.00028	CbGpPWpGaD
Dronabinol—CYP3A4—Metabolism—NAT1—urinary bladder cancer	2.79e-05	0.00028	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—EP300—urinary bladder cancer	2.77e-05	0.000279	CbGpPWpGaD
Dronabinol—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2.75e-05	0.000277	CbGpPWpGaD
Dronabinol—ABCB1—Metabolism—TYMP—urinary bladder cancer	2.74e-05	0.000276	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—SRC—urinary bladder cancer	2.7e-05	0.000271	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	2.7e-05	0.000271	CbGpPWpGaD
Dronabinol—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	2.69e-05	0.000271	CbGpPWpGaD
Dronabinol—CYP2A6—Metabolism—NQO1—urinary bladder cancer	2.68e-05	0.00027	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism—RRM2—urinary bladder cancer	2.68e-05	0.00027	CbGpPWpGaD
Dronabinol—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	2.63e-05	0.000265	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	2.57e-05	0.000258	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism—TYMP—urinary bladder cancer	2.56e-05	0.000258	CbGpPWpGaD
Dronabinol—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	2.55e-05	0.000256	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism—NAT2—urinary bladder cancer	2.54e-05	0.000256	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—TP53—urinary bladder cancer	2.53e-05	0.000255	CbGpPWpGaD
Dronabinol—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	2.5e-05	0.000252	CbGpPWpGaD
Dronabinol—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	2.48e-05	0.00025	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism—HPGDS—urinary bladder cancer	2.48e-05	0.00025	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism—ENO2—urinary bladder cancer	2.48e-05	0.00025	CbGpPWpGaD
Dronabinol—ABCB1—Metabolism—NAT2—urinary bladder cancer	2.48e-05	0.000249	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	2.47e-05	0.000248	CbGpPWpGaD
Dronabinol—ABCG2—Metabolism—GSTP1—urinary bladder cancer	2.46e-05	0.000248	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	2.46e-05	0.000247	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—HRAS—urinary bladder cancer	2.42e-05	0.000243	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—MYC—urinary bladder cancer	2.42e-05	0.000243	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism—GSTT1—urinary bladder cancer	2.41e-05	0.000242	CbGpPWpGaD
Dronabinol—PTGS1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.4e-05	0.000242	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	2.37e-05	0.000238	CbGpPWpGaD
Dronabinol—PTGS1—Metabolism—GSTP1—urinary bladder cancer	2.37e-05	0.000238	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—EGFR—urinary bladder cancer	2.36e-05	0.000238	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism—NAT2—urinary bladder cancer	2.31e-05	0.000233	CbGpPWpGaD
Dronabinol—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	2.29e-05	0.000231	CbGpPWpGaD
Dronabinol—ABCG2—Metabolism—TYMS—urinary bladder cancer	2.29e-05	0.00023	CbGpPWpGaD
Dronabinol—PTGS1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.29e-05	0.00023	CbGpPWpGaD
Dronabinol—ABCG2—Metabolism—GSTM1—urinary bladder cancer	2.26e-05	0.000228	CbGpPWpGaD
Dronabinol—ABCG2—Metabolism—NCOR1—urinary bladder cancer	2.26e-05	0.000228	CbGpPWpGaD
Dronabinol—CYP2A6—Metabolism—GSTP1—urinary bladder cancer	2.24e-05	0.000225	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—KRAS—urinary bladder cancer	2.23e-05	0.000225	CbGpPWpGaD
Dronabinol—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	2.21e-05	0.000222	CbGpPWpGaD
Dronabinol—PTGS1—Metabolism—TYMS—urinary bladder cancer	2.2e-05	0.000221	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism—RRM2—urinary bladder cancer	2.19e-05	0.000221	CbGpPWpGaD
Dronabinol—PTGS1—Metabolism—NCOR1—urinary bladder cancer	2.17e-05	0.000219	CbGpPWpGaD
Dronabinol—PTGS1—Metabolism—GSTM1—urinary bladder cancer	2.17e-05	0.000219	CbGpPWpGaD
Dronabinol—ABCG2—Metabolism—GPX1—urinary bladder cancer	2.17e-05	0.000218	CbGpPWpGaD
Dronabinol—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	2.17e-05	0.000218	CbGpPWpGaD
Dronabinol—ABCB1—Metabolism—RRM2—urinary bladder cancer	2.14e-05	0.000215	CbGpPWpGaD
Dronabinol—ABCG2—Metabolism—ERCC2—urinary bladder cancer	2.13e-05	0.000214	CbGpPWpGaD
Dronabinol—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	2.11e-05	0.000213	CbGpPWpGaD
Dronabinol—PTGS1—Metabolism—GPX1—urinary bladder cancer	2.08e-05	0.00021	CbGpPWpGaD
Dronabinol—CYP2A6—Metabolism—TYMS—urinary bladder cancer	2.08e-05	0.000209	CbGpPWpGaD
Dronabinol—CYP2A6—Metabolism—GSTM1—urinary bladder cancer	2.06e-05	0.000207	CbGpPWpGaD
Dronabinol—CYP2A6—Metabolism—NCOR1—urinary bladder cancer	2.06e-05	0.000207	CbGpPWpGaD
Dronabinol—PTGS1—Metabolism—ERCC2—urinary bladder cancer	2.04e-05	0.000206	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism—ENO2—urinary bladder cancer	2.03e-05	0.000204	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism—HPGDS—urinary bladder cancer	2.03e-05	0.000204	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	2.02e-05	0.000203	CbGpPWpGaD
Dronabinol—ABCG2—Metabolism—MTHFR—urinary bladder cancer	2e-05	0.000201	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism—NQO1—urinary bladder cancer	2e-05	0.000201	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism—RRM2—urinary bladder cancer	2e-05	0.000201	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—TP53—urinary bladder cancer	1.98e-05	0.0002	CbGpPWpGaD
Dronabinol—ABCB1—Metabolism—HPGDS—urinary bladder cancer	1.98e-05	0.000199	CbGpPWpGaD
Dronabinol—ABCB1—Metabolism—ENO2—urinary bladder cancer	1.98e-05	0.000199	CbGpPWpGaD
Dronabinol—CYP2A6—Metabolism—GPX1—urinary bladder cancer	1.97e-05	0.000198	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism—GSTT1—urinary bladder cancer	1.97e-05	0.000198	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.94e-05	0.000195	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.94e-05	0.000195	CbGpPWpGaD
Dronabinol—CYP2A6—Metabolism—ERCC2—urinary bladder cancer	1.93e-05	0.000195	CbGpPWpGaD
Dronabinol—PTGS1—Metabolism—MTHFR—urinary bladder cancer	1.92e-05	0.000193	CbGpPWpGaD
Dronabinol—ABCB1—Metabolism—GSTT1—urinary bladder cancer	1.92e-05	0.000193	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—HRAS—urinary bladder cancer	1.9e-05	0.000191	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism—HPGDS—urinary bladder cancer	1.85e-05	0.000186	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism—ENO2—urinary bladder cancer	1.85e-05	0.000186	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.84e-05	0.000185	CbGpPWpGaD
Dronabinol—CYP2A6—Metabolism—MTHFR—urinary bladder cancer	1.82e-05	0.000183	CbGpPWpGaD
Dronabinol—ABCB1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	1.8e-05	0.000181	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism—GSTT1—urinary bladder cancer	1.79e-05	0.000181	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.77e-05	0.000178	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.69e-05	0.00017	CbGpPWpGaD
Dronabinol—CYP3A4—Metabolism—TYMP—urinary bladder cancer	1.69e-05	0.00017	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism—GSTP1—urinary bladder cancer	1.67e-05	0.000168	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism—NQO1—urinary bladder cancer	1.64e-05	0.000165	CbGpPWpGaD
Dronabinol—ABCG2—Metabolism—PPARG—urinary bladder cancer	1.62e-05	0.000163	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.61e-05	0.000162	CbGpPWpGaD
Dronabinol—ABCB1—Metabolism—NQO1—urinary bladder cancer	1.6e-05	0.000161	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.59e-05	0.00016	CbGpPWpGaD
Dronabinol—PTGS1—Metabolism—PPARG—urinary bladder cancer	1.56e-05	0.000157	CbGpPWpGaD
Dronabinol—ABCG2—Metabolism—CREBBP—urinary bladder cancer	1.56e-05	0.000157	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism—TYMS—urinary bladder cancer	1.55e-05	0.000156	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism—NCOR1—urinary bladder cancer	1.53e-05	0.000154	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism—GSTM1—urinary bladder cancer	1.53e-05	0.000154	CbGpPWpGaD
Dronabinol—CYP3A4—Metabolism—NAT2—urinary bladder cancer	1.53e-05	0.000154	CbGpPWpGaD
Dronabinol—PTGS1—Metabolism—CREBBP—urinary bladder cancer	1.5e-05	0.000151	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism—NQO1—urinary bladder cancer	1.49e-05	0.00015	CbGpPWpGaD
Dronabinol—CYP2A6—Metabolism—PPARG—urinary bladder cancer	1.47e-05	0.000148	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism—GPX1—urinary bladder cancer	1.47e-05	0.000148	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.45e-05	0.000146	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism—ERCC2—urinary bladder cancer	1.44e-05	0.000145	CbGpPWpGaD
Dronabinol—CYP2A6—Metabolism—CREBBP—urinary bladder cancer	1.42e-05	0.000142	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.38e-05	0.000139	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism—GSTP1—urinary bladder cancer	1.36e-05	0.000137	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism—MTHFR—urinary bladder cancer	1.35e-05	0.000136	CbGpPWpGaD
Dronabinol—ABCB1—Metabolism—GSTP1—urinary bladder cancer	1.33e-05	0.000134	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.32e-05	0.000133	CbGpPWpGaD
Dronabinol—CYP3A4—Metabolism—RRM2—urinary bladder cancer	1.32e-05	0.000133	CbGpPWpGaD
Dronabinol—ABCG2—Metabolism—PTGS2—urinary bladder cancer	1.28e-05	0.000128	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism—TYMS—urinary bladder cancer	1.27e-05	0.000128	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.26e-05	0.000127	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism—NCOR1—urinary bladder cancer	1.25e-05	0.000126	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism—GSTM1—urinary bladder cancer	1.25e-05	0.000126	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism—GSTP1—urinary bladder cancer	1.24e-05	0.000125	CbGpPWpGaD
Dronabinol—ABCB1—Metabolism—TYMS—urinary bladder cancer	1.24e-05	0.000125	CbGpPWpGaD
Dronabinol—PTGS1—Metabolism—PTGS2—urinary bladder cancer	1.23e-05	0.000123	CbGpPWpGaD
Dronabinol—ABCB1—Metabolism—NCOR1—urinary bladder cancer	1.22e-05	0.000123	CbGpPWpGaD
Dronabinol—ABCB1—Metabolism—GSTM1—urinary bladder cancer	1.22e-05	0.000123	CbGpPWpGaD
Dronabinol—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	1.22e-05	0.000123	CbGpPWpGaD
Dronabinol—CYP3A4—Metabolism—ENO2—urinary bladder cancer	1.22e-05	0.000123	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.2e-05	0.000121	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism—GPX1—urinary bladder cancer	1.2e-05	0.000121	CbGpPWpGaD
Dronabinol—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	1.18e-05	0.000119	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism—ERCC2—urinary bladder cancer	1.18e-05	0.000119	CbGpPWpGaD
Dronabinol—ABCB1—Metabolism—GPX1—urinary bladder cancer	1.17e-05	0.000118	CbGpPWpGaD
Dronabinol—CYP2A6—Metabolism—PTGS2—urinary bladder cancer	1.16e-05	0.000117	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism—TYMS—urinary bladder cancer	1.16e-05	0.000116	CbGpPWpGaD
Dronabinol—ABCB1—Metabolism—ERCC2—urinary bladder cancer	1.15e-05	0.000116	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism—NCOR1—urinary bladder cancer	1.14e-05	0.000115	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism—GSTM1—urinary bladder cancer	1.14e-05	0.000115	CbGpPWpGaD
Dronabinol—ABCG2—Metabolism—PTEN—urinary bladder cancer	1.11e-05	0.000112	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism—MTHFR—urinary bladder cancer	1.11e-05	0.000112	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism—PPARG—urinary bladder cancer	1.1e-05	0.000111	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism—GPX1—urinary bladder cancer	1.09e-05	0.00011	CbGpPWpGaD
Dronabinol—ABCB1—Metabolism—MTHFR—urinary bladder cancer	1.08e-05	0.000109	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism—ERCC2—urinary bladder cancer	1.07e-05	0.000108	CbGpPWpGaD
Dronabinol—PTGS1—Metabolism—PTEN—urinary bladder cancer	1.07e-05	0.000108	CbGpPWpGaD
Dronabinol—ABCG2—Metabolism—EP300—urinary bladder cancer	1.06e-05	0.000107	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism—CREBBP—urinary bladder cancer	1.05e-05	0.000106	CbGpPWpGaD
Dronabinol—PTGS1—Metabolism—EP300—urinary bladder cancer	1.02e-05	0.000103	CbGpPWpGaD
Dronabinol—CYP2A6—Metabolism—PTEN—urinary bladder cancer	1.01e-05	0.000102	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism—MTHFR—urinary bladder cancer	1.01e-05	0.000102	CbGpPWpGaD
Dronabinol—CYP3A4—Metabolism—NQO1—urinary bladder cancer	9.84e-06	9.9e-05	CbGpPWpGaD
Dronabinol—CYP2A6—Metabolism—EP300—urinary bladder cancer	9.64e-06	9.7e-05	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism—PPARG—urinary bladder cancer	8.98e-06	9.04e-05	CbGpPWpGaD
Dronabinol—ABCB1—Metabolism—PPARG—urinary bladder cancer	8.77e-06	8.83e-05	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism—PTGS2—urinary bladder cancer	8.64e-06	8.69e-05	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism—CREBBP—urinary bladder cancer	8.63e-06	8.69e-05	CbGpPWpGaD
Dronabinol—ABCB1—Metabolism—CREBBP—urinary bladder cancer	8.42e-06	8.48e-05	CbGpPWpGaD
Dronabinol—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	8.2e-06	8.26e-05	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism—PPARG—urinary bladder cancer	8.19e-06	8.25e-05	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism—CREBBP—urinary bladder cancer	7.87e-06	7.92e-05	CbGpPWpGaD
Dronabinol—CYP3A4—Metabolism—TYMS—urinary bladder cancer	7.63e-06	7.68e-05	CbGpPWpGaD
Dronabinol—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	7.54e-06	7.59e-05	CbGpPWpGaD
Dronabinol—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	7.54e-06	7.59e-05	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism—PTEN—urinary bladder cancer	7.53e-06	7.58e-05	CbGpPWpGaD
Dronabinol—CYP3A4—Metabolism—GPX1—urinary bladder cancer	7.22e-06	7.27e-05	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism—EP300—urinary bladder cancer	7.18e-06	7.23e-05	CbGpPWpGaD
Dronabinol—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	7.09e-06	7.13e-05	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism—PTGS2—urinary bladder cancer	7.07e-06	7.11e-05	CbGpPWpGaD
Dronabinol—ABCB1—Metabolism—PTGS2—urinary bladder cancer	6.9e-06	6.94e-05	CbGpPWpGaD
Dronabinol—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	6.66e-06	6.71e-05	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism—PTGS2—urinary bladder cancer	6.44e-06	6.49e-05	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism—PTEN—urinary bladder cancer	6.16e-06	6.2e-05	CbGpPWpGaD
Dronabinol—ABCB1—Metabolism—PTEN—urinary bladder cancer	6.02e-06	6.06e-05	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism—EP300—urinary bladder cancer	5.88e-06	5.92e-05	CbGpPWpGaD
Dronabinol—ABCB1—Metabolism—EP300—urinary bladder cancer	5.74e-06	5.78e-05	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism—PTEN—urinary bladder cancer	5.62e-06	5.66e-05	CbGpPWpGaD
Dronabinol—CYP3A4—Metabolism—PPARG—urinary bladder cancer	5.4e-06	5.44e-05	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism—EP300—urinary bladder cancer	5.36e-06	5.4e-05	CbGpPWpGaD
Dronabinol—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	5.19e-06	5.22e-05	CbGpPWpGaD
Dronabinol—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	4.25e-06	4.28e-05	CbGpPWpGaD
Dronabinol—CYP3A4—Metabolism—PTEN—urinary bladder cancer	3.71e-06	3.73e-05	CbGpPWpGaD
Dronabinol—CYP3A4—Metabolism—EP300—urinary bladder cancer	3.53e-06	3.56e-05	CbGpPWpGaD
